• Skip to primary navigation
  • Skip to main content

New Mexico Angels

Investing in Innovation

  • Home
  • About Us
    • Team & Board
    • Education & Community
    • Portfolio
    • Sponsors
    • Sponsorship Opportunities
  • Angel Investors
    • Become an Angel
    • Membership FAQ
    • Angel Tax Credit
  • Entrepreneurs
    • Investment Criteria
    • Submission Process – Apply for Angel Funding
    • Presentation Guidelines
  • News
  • Events
  • Contact Us

GPER G-1 Development Company

October 24, 2019

GPER G-1 is a drug discovery and development company with the primary goal of advancing pre-clinical development of novel drug candidates that modulate the G-Protein Coupled Estrogen Receptor (GPER). The lead drug candidate is G-1 (EsperaTM), which is a GPER agonist to treat obesity through weight loss, and to reverse diabetes and pre-diabetes.

Copyright © 2021 NEW MEXICO ANGELS. ALL RIGHTS RESERVED.